Market Place
Sourcing Support
AZN completes transfer of global rights to Eklira & Duaklir to Covis Pharma
06 Jan 2022 //
PHARMABIZ
AstraZeneca sells 2 COPD inhalers to familiar face
02 Nov 2021 //
FIERCEPHARMA
A three-decade monopoly: How Amgen built a patent thicket top-selling drug
30 Oct 2021 //
BIOPHARMADIVE
Circassia Pharmaceuticals launches DUAKLIR® PRESSAIR® for patients with COPD
21 Oct 2019 //
BIOSPACE
US Food and Drug Administration Approves DUAKLIR® PRESSAIR®
17 Apr 2019 //
BUSINESSWIRE
FDA Approves TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) sNDA)
01 Apr 2019 //
BUSINESSWIRE
AZ’ Tudorza hits study goals in COPD patients with CV risk factors
05 Dec 2017 //
PHARMA TIMES
AZ announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD
04 Dec 2017 //
PHARMABIZ
Five pharmas Fall Foul of ABPI Code of Practice
15 Dec 2016 //
PHARMATIMES
US FDA Enforcement report- 30/Mar/2016
28 Mar 2016 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.